Acrux (ASX:ACR) Accounts Payable

: A$3.28 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

Acrux's Accounts Payable for the quarter that ended in Dec. 2023 was A$3.28 Mil.

Acrux's quarterly Accounts Payable declined from Dec. 2022 (A$1.48 Mil) to Jun. 2023 (A$0.49 Mil) but then increased from Jun. 2023 (A$0.49 Mil) to Dec. 2023 (A$3.28 Mil).

Acrux's annual Accounts Payable increased from Jun. 2021 (A$0.31 Mil) to Jun. 2022 (A$0.79 Mil) but then declined from Jun. 2022 (A$0.79 Mil) to Jun. 2023 (A$0.49 Mil).

Acrux Accounts Payable Historical Data

The historical data trend for Acrux's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrux Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable

0.90

1.03

0.31

0.79

0.49

Acrux Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable																0.95	0.79	1.48	0.49	3.28

Acrux Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Acrux Accounts Payable Related Terms

Thank you for viewing the detailed overview of Acrux's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Acrux (ASX:ACR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (ASX:ACR) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

ARUXF:USA FJY:Germany

Address

103-113 Stanley Street, West Melbourne, Melbourne, VIC, AUS, 3003

Website

https://www.acrux.com.au

Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.